KolateAI
Clinical trials + RWE
Prediction engine
Gen AI for Pharma
Patient-level Clinical Events Prediction engine to accelerate pharma trials and real-world studies.
Focus: Oncology, Neuroscience, Immunology and Rare Diseases.
partner with us
Holistic AI Insights Engine for your Entire Drug Development Lifecycle
- Plan transition between phases with unique insights for protocol development and trial setup.
- Incorporate real-world insights in real-time, and monitor competitor trials, drug approvals, and product market shares in your development program.
- Proactive insights are generated on a chatbot that is bespoke for your program.
- A tool for pharma executives and decision-makers to take tough calls and move the needle on drug programs.
Get the direction of your drug trial
Use cases of Kolate.AI: With our pre-built AI foundation model predictions of upcoming Serious Adverse Events (SAE’s), AE’s, drug response, trial endpoints, working in concert with our Co-pilot, we address the following use cases:
- Identify best-performing patient clusters (i.e. best drug response with fewest side effects) in advance
- Provide early view of trial direction (comparing “treatment” vs “control” arms)
- Enable effective trial management with real-time clinical and operational insights
- Predict real-world clinical outcomes (e.g. drug efficacy, side effects, diagnostic risk scores, etc.) using Real-World data
Insights queried via our Gen AI Co-pilot
Speed up drug development
- With real-time insights, make operational study updates or stop a non-working trial sooner.
- Plan additional studies based on the trial insights, is a sub-group working better, are there biomarkers that can increase drug efficacy or should there be any changes made to the inclusion/exclusion criteria?
- Understand the drug better compared to competitors. Are there aspects of the drug that can be improved including dose, time of administration, and method of administration?
- Generate additional insights to support your drug submissions. Can you claim higher efficacy and lower side effects, parameters that would increase your reimbursement prospects?
- Plan for future studies, or in the case of adaptive studies, get insights on what additional tweaks you can make in real-time to improve study outcomes.
Partners
KolateAI has been accepted into the JLABS eco-system
Selected by ERA (top accelerator) for winter cohort Jan 24, one of just 16 out of a very large pool of applicants, provides funding and growth platform
About us
We are a team of tech-savvy repeat entrepreneurs with deep pharma industry background, and a demonstrated track record in business growth and execution. We have experienced the problems with drug development firsthand.
Vinodh Balaraman, CEO
Vinodh is a world-class healthcare exec with a proven track record of building tech-based businesses and is a repeat entrepreneur. He has worked on large life sciences consulting assignments and led multifold growth in many situations, including as a Senior Partner at ZS and SVP at Atos. He is an IIT Chennai graduate and has an MBA from Chicago Booth
Speed up your drug trials with real-time trial insights
Reduce time and cost of drug development
Develop greater number of drugs
partner with us
vinodh@kolate.ai
KolateAI PharmaTech Inc
Belle Mead, NJ
